Assignee
MEDIPOST CO LTD
KR·9 granted patents·13 pending applications·24 citations·filing 2002–2022
Top patents by PatentIndex Score
22 records- 0183US7459307B2Composition for treatment of articular cartilage damageMEDIPOST CO LTD·Filed 2002·Granted Dec 2, 2008·24 cites·33 claims
- 0269US11332715B2Method for culturing mesenchymal stem cellsMEDIPOST CO LTD·Filed 2019·Granted May 17, 2022·0 cites·8 claims
- 0369US2009022698A1Composition For Treatment Of Articular Cartilage DamageMEDIPOST CO LTD·Filed 2008·Application pending·0 cites
- 0469US2009047261A1Composition For Treatment Of Articular Cartilage DamageMEDIPOST CO LTD·Filed 2008·Application pending·0 cites
- 0559US2009060885A1Composition For Treatment of Articular Cartilage DamageMEDIPOST CO LTD·Filed 2008·Application pending·0 cites
- 0659US2021220256A1Hair growth promoting capacity of conditioned media of stimulated stem cells and use thereofMEDIPOST CO LTD·Filed 2021·Application pending·0 cites
- 0757US9580687B2Method for culturing mesenchymal stem cellsMEDIPOST CO LTD·Filed 2013·Granted Feb 28, 2017·0 cites·8 claims
- 0857US2010184218A1Isolation and Culture-Expansion Methods of Mesenchymal Stem/Progenitor Cells From Umbilical Cord Blood, And Differentiation Method of Umbilical Cord Blood-Derived Meschymal Stem/Progenitor Cells Into Various Mesenchymal TissuesMEDIPOST CO LTD·Filed 2009·Application pending·0 cites
- 0956US9408892B2Treating cartilage defect with UCB-MSC expressing TSP-2MEDIPOST CO LTD·Filed 2013·Granted Aug 9, 2016·0 cites·1 claims
- 1055US2025073273A1Pharmaceutical composition for prevention or treatment of inflammatory disease or pain, comprising mesenchymal stem cells expressing ptx-3, timp1 and bdnf as active ingredientMEDIPOST CO LTD·Filed 2021·Application pending·0 cites
- 1154US10294456B2Method for culturing mesenchymal stem cellsMEDIPOST CO LTD·Filed 2017·Granted May 21, 2019·0 cites·9 claims
- 1252US2018008531A1Capability of small-sized stem cells to stimulate hair growth and use thereofMEDIPOST CO LTD·Filed 2017·Application pending·0 cites
- 1351US2013189189A1COMPOSITION FOR THE DIAGNOSIS, PREVENTION OR TREATMENT OF DISEASES RELATED TO CELLS EXPRESSING IL-8 OR GRO-ALPHA, COMPRISING UCB-MSCsMEDIPOST CO LTD·Filed 2012·Application pending·0 cites
- 1451US2025017975A1Composition for preventing or treating lung diseases containing cd47-overexpressing mesenchymal stem cellsMEDIPOST CO LTD·Filed 2022·Application pending·0 cites
- 1550US2007178073A1Composition Comprising Separated or Proliferated Cells from Umbilical Cord Blood for Treating Developmental and/or Chronic Lung DiseaseMEDIPOST CO LTD·Filed 2006·Application pending·0 cites
- 1649US10150950B2Method for culturing mesenchymal stem cells according to cell sizeMEDIPOST CO LTD·Filed 2014·Granted Dec 11, 2018·0 cites·11 claims
- 1749US9439931B2Administering umbilical cord blood-derived mesenchymal stem cells to treat nerve injuryMEDIPOST CO LTD·Filed 2013·Granted Sep 13, 2016·0 cites·2 claims
- 1846US10307442B2Pharmaceutical composition for the prevention or treatment of a pulmonary disorder comprising mesenchymal stem cells having improved proliferation and differentiation capacityMEDIPOST CO LTD·Filed 2016·Granted Jun 4, 2019·0 cites·15 claims
- 1945US2016000698A1Capability of small-sized stem cells to stimulate hair growth and use thereofMEDIPOST CO LTD·Filed 2015·Application pending·0 cites
- 2043US12303534B2Pharmaceutical composition comprising mesenchymal stem cells as effective ingredient for prevention or treatment of inflammatory diseaseMEDIPOST CO LTD·Filed 2019·Granted May 20, 2025·0 cites·8 claims
- 2138US2006024825A1Method of promoting expansion of stem cellsMEDIPOST CO LTD·Filed 2005·Application pending·0 cites
- 2237US2016000699A1Hair growth promoting capacity of conditioned media of stimulated stem cells and use thereofMEDIPOST CO LTD·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when MEDIPOST CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →